Statistics about Health, Pharma & Medtech in United States
Statistics
- Key figures on U.S. blood plasma market 2015
- Premiums for public U.S. biopharma company trade sales 2010-2019
- Patents in life sciences industry in the U.S. by state 2018-2023
- Value forecast U.S. pharmaceutical empty capsules market 2021-2032
- Medtech companies market cap growth U.S. and Europe 2016-2021
- US and European biopharma company M&A transaction volumes by type 2010-2019
- U.S. development phase success rates for drugs with and without biomarkers 2011-2020
- U.S. development Phase success rates for rare and common disease drugs 2011-2020
- Expected acquisitions of biopharma companies by type of asset 2021
- Expected investment changes in biopharma and diagnostic lab services 2021
- 1-year probability of default median for public U.S. healthcare industries 2020-2021
- U.S. drug development Phase success rates, by drug classification 2011-2020
- Prescriptions of unbranded generics by top companies U.S. 2017-2018
- Medtech ventures based on gross raised in the U.S. 2022/23
- Hemophilia market size in the U.S. 2022-2030
- Top known pharma companies by Americans and gender 2017
- US adults' rating of impact of economic situations on U.S. pharma by gender 2017
- Number of life sciences graduates in U.S. cluster proximity 2018
- Share of generics in prescription growth in U.S. 2014-2015
- U.S. drug development phase III success rates 2011-2020, by disease area
- Top pharmaceutical manufacturer vs. top pharmaceutical distributor U.S. 2019
- Origin of new drugs licensed or acquired, 2014-2018, by company size
- U.S. adults rating selected pharma features as excellent or good by gender 2017
- Growing unbranded generic corporations by absolute Rx growth U.S. 2017-2018
- Unbranded generic corporations in U.S. 2017-2018, by absolute dollar growth
- Unbranded generics revenue top corporations in U.S. 2017-2018
- U.S. contraceptive market size 2017 vs. 2025, by product
- Clinical CRO market share worldwide by company 2016
- US adults on research results impact on U.S. pharma industry by gender 2017
- List of top health care equipment and service U.S. companies 2024 by net income
- Americans' impression of the US pharma industry quality of research, by gender 2017
- Unbranded generics market share top corporations in U.S. 2017-2018
- Leading venture capital firms in U.S. healthcare in Q4 2020, by number of deals
- U.S. development Phase success rates for oncology and non oncology drugs 2011-2020
- Share of pharmaceutical recalls in the U.S. by cause 2019
- Total value of healthcare financing deals in the U.S. in Q4 2020, by top states
- Planned and actual healthcare and life sciences activity in 2020, by subsector
- US adults' rating of fairness towards patients by pharma industry, by gender 2017
- US adults that believe physicians are pressured to prescribe drugs, by ethnicity
- Impact of COVID-19 on U.S. pharma/clinical engagement 2020
- Impact of COVID-19 pandemic on U.S. liaisons/clinical engagement 2020
- Total global volume of plasma produced 1990-2018
- Medical devices market value in the United States 2021-2027
- Global distribution of blood plasma produced by region 2015
- U.S. pain medication clinical pipeline in 2017, by phase and indication
- Technological advances in the genome sequencing area 2003-2020
- Expected consequences of moving US pharma manufacturing to the US, by gender
- Americans' preferred pharma companies for drug purchase, by gender 2017
- Americans on US pharma quality compared to foreign pharma 2017, by gender
- Pharma and life sciences executives' workforce strategy priorities U.S. 2020
- Expected valuation changes in healthcare and life sciences 2021, by subsector
- Number of units per pharmaceutical product recall in the U.S. 2014-2019
- Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Rate of approval for Indian pharma ANDA by U.S. FDA 2017-2019
- U.S. market size of propofol 2010-2013
- Number of Indian ANDA approvals by the U.S. FDA 2017-2019
- U.S. drug development phase success rates 2011-2020
- Value of Indian drugs and pharmaceutical exports FY 2017-2019
- Type 2 diabetes clinical pipeline in the U.S. in 2018, by type and phase
- Share of Americans who say certain groups have too much influence in D.C. 2018
- U.S. drug development phase II success rates 2011-2020, by disease area
- U.S. drug development phase I to approval success rates 2011-2020 by disease area
- Number of employees at Athenahealth 2015-2017 by department
- NDA/BLA filing to FDA approval times for new drugs in select disease areas 2011-2020
- Share price change in select U.S.-listed Chinese biopharma companies 2022
- Total value of healthcare financing deals in the U.S. in Q4 2020, by region
- Heska revenue 2015-2022
- Medical marijuana packaging market value U.S. 2020-2030
- U.S. adults impression of the U.S. pharma companies labor conditions
- Median salaries in U.S. medtech industry by occupational field 2016
- Opinion on having been prescribed a not really needed drug by age 2017
- Leading California life sciences organizations receiving NSF funding 2022
- VC deal count and capital invested in US life sciences by sector 2022
- Leading U.S. states by healthcare VC investment 2022
- Leading U.S. states by healthcare VC investment deals 2022
- Number of M&A healthcare deals in California and the U.S. in 2021, by sector
- Share of health and life sciences workers in California 2015-2021, by ethnicity
- Share of U.S. adults supporting government negotiations for lower drug prices 2021
- Selected major medtech IPOs in Asia-Pacific by proceeds 2016-2017
- US adults that trust their doctor in prescribing appropriate drugs, by age
- Experience of carpal tunnel surgery with and without VR in the U.S. 2021
- Americans' impression of the US pharma industry pricing, by gender 2017
- Publicy reported investments among the top 10 medtech companies 2018
- Size of life sciences establishments in California in 2021, by number of employees
- Share of company sales of biggest selling drugs going generic in the U.S. in 2017
- Change in list and net drug prices select manufacturers U.S. 2017-2022
- Active spinal muscular atrophy clinical trials by region and phase 2023
- U.S. share of life sciences M&A deal value worldwide 2015-2017
- U.S. adults impression of the U.S. pharma industry
- Reduction from list price of pharmaceutical products by manufacturer U.S. 2022
- Change in U.S. list and net drug prices 2022 by manufacturer
- In-state vs out-of-state cannabis shopping Illinois Jan-Apr 2021
- U.S. adults impression of the U.S. pharma drug qualities
- M&A deal value in the medical technology industry in the U.S. 2015-2024
- U.S. and Europe biopharma company transaction volume 2009-2019
- Number of U.S. biopharma M&A deals 2015-2019, by transaction volume
- Digital health mega deals as a share of total funding in the U.S. 2017-2022
- Share of total life sciences unique job postings in California vs U.S. 2019-2022
- Californian organizations which received the highest funding from the NIH 2021
- List of top health care equipment and service U.S. companies in 2024 by revenue